- Anna's DayBreak News
- Posts
- Travel Bans are Back, Fed’s Beige Book and Newborn Gene Therapy
Travel Bans are Back, Fed’s Beige Book and Newborn Gene Therapy
Anna's Daybreak News
Just facts, you think for yourself
Thursday, 5:23 AM
June 5, 2025
Good morning news friend! Follow the pulse of today’s world as it shapes the path to tomorrow. 📰🌟
Click here to read the poll results and comments from our previous edition. Over 4,286 people gave their opinion about the doubling of steel tariffs, US-China relations and more!
Can’t see all 6 articles in this email? The Gmail app sometimes crops our emails, click here to view full edition.
Trump Reinstates Travel Bans
President Trump announced a travel ban affecting citizens from 12 countries, effective June 9, 2025.
The banned countries include Afghanistan, Myanmar, Chad, the Republic of Congo, Equatorial Guinea, Eritrea, Haiti, Iran, Libya, Somalia, Sudan, and Yemen. Seven additional nations face stricter entry requirements, these include Burundi, Cuba, Laos, Sierra Leone, Togo, Turkmenistan, and Venezuela.
Trump cited national security concerns linked to a recent terror attack in Boulder, Colorado, and indicated that these countries have poor screening processes.
Sources: AP News, Reuters, FinancialTimes, WallStreetJournal.
How do you feel about this move in light of the recent terror attack in Colorado?Click to see live results and comment! |
This free version is ad-supported.
Over 50 million Americans, including those with demanding jobs, active lifestyles, or conditions like arthritis, struggle with chronic pain. Many also face harmful side effects from opioids, steroids, and over-the-counter painkillers. Nápreva's plant-based terpene formula provides rapid relief, helping users sleep better and reduce stress and anxiety. Clinical studies suggest terpenes may offer more effective relief than traditional drugs—without the unwanted side effects.
Try Nápreva today! Enjoy a money-back guarantee and experience the healing power of plants.
Don’t want to see ads anymore? Click here for an ad-free experience (only $5 per month)
23andMe's Bidding Battle
23andMe, a bankrupt genetic analysis firm, has initiated a second auction after a $305 million bid from co-founder Anne Wojcicki’s nonprofit, TTAM Research Institute, exceeding Regeneron Pharmaceuticals' earlier $256 million offer.
The original winning bid was contested in court by Wojcicki. A U.S. Bankruptcy Judge questioned auction limits, prompting both parties to defend their rules.
23andMe has struggled since its Chapter 11 filing in March, affected by declining demand and a data breach exposing customer DNA information. Regeneron plans another bid and seeks a $10 million breakup fee if Wojcicki prevails.
Sources: Bloomberg, Bloomberg, Reuters, Finimize, WallStreetJournal.
Should the management of genetic data be considered a public good rather than a commercial commodity?Click to see live results and comment! |
This free version is ad-supported.
Learn AI skills for any industry and get hands-on experience using the latest tools in tech. Anna’s Daybreak News readers can get 15% off a year of Codecademy Pro when you use code SKILLUP15.
Don’t want to see ads anymore? Click here for an ad-free experience (only $5 per month)
Fed’s Beige Book Report
Half of the Federal Reserve's districts have reported declines. Only three out of twelve reported growth.
The nonmanufacturing PMI dropped to 49.9 in May, indicating a contraction in the services sector. Consumer spending is weakening, and May's private payroll growth was just 37,000, the lowest since March 2023. Input prices surged to a two-year high, causing hesitation in business planning.
Firms may pass increased costs onto consumers in the near future. The ISM reported prices paid for service inputs surged to 68.7, the highest in two years.
Sources: Reuters, Reuters, Bloomberg, Economictimes, CNBC.
How do you feel about the current state of the U.S. economy?Click to see live results and comment! |
This free version is ad-supported.
Join over 4 million Americans who start their day with 1440 – your daily digest for unbiased, fact-centric news. From politics to sports, we cover it all by analyzing over 100 sources. Our concise, 5-minute read lands in your inbox each morning at no cost. Experience news without the noise; let 1440 help you make up your own mind.
Don’t want to see ads anymore? Click here for an ad-free experience (only $5 per month)
OpenAI Battles Court Order
OpenAI is battling a court order to preserve all user logs from ChatGPT, including deleted chats and sensitive API conversations.
This ruling stems from accusations of evidence destruction in a copyright lawsuit. OpenAI argues the order infringes on user privacy, as it must retain data even when users delete it.
The order raises concerns for business clients, potentially exposing sensitive information. Users express alarm over privacy risks, affecting OpenAI's reputation.
OpenAI is actively contesting the order to protect user interests and maintain its commitment to privacy and safety.
Sources: Arstechnica, Gigazine, Adweek.
Should users have the right to permanently delete all their chat data with AI services?Click to see live results and comment! |
Treating Genetic Disorders in Newborns
Researchers at the San Raffaele-Telethon Institute have found a postnatal window in newborn mice ideal for gene therapy targeting blood stem cells.
This period, especially within the first two weeks, allows direct injection of lentiviral vectors, avoiding invasive procedures. Experiments showed that a single intravenous injection improved outcomes for three genetic diseases.
Mobilizing drugs extended the treatment window by increasing circulating stem cell numbers. Circulating hematopoietic stem cells were also detected in human newborns, indicating potential for human application.
Additionally, CRISPR-Cas9 gene editing was found to provoke inflammation in stem cells, suggesting complications in treatment outcomes, leading to proposed mitigation strategies.
Sources: SciTechDaily, EurekAlert, TheMedicineMaker, Medicalxpress.
Do you think gene editing should be considered for routine treatments of genetic disorders?Click to see live results and comment! |
Transforming Crude Oil Separation
MIT researchers developed a membrane technology that separates crude oil by molecular size, potentially reducing energy consumption and carbon emissions in oil processing.
Traditional crude oil distillation is energy-intensive, accounting for 6% of global CO2 emissions. The new approach uses a thin film for molecular filtration instead of heat, enhancing efficiency.
Researchers modified polyamide membranes for water desalination, improving them with stronger imine bonds to maintain filtering capabilities. In tests, the membrane concentrated toluene significantly and separated lighter and heavier hydrocarbons.
This innovation could replace conventional fractionation columns and support large-scale production using established manufacturing practices. The research is backed by ExxonMobil.
Sources: SciTechDaily, Globalenergyprize, TechnologyNetworks.
How do you perceive the role of academic research in solving energy-related issues?Click to see live results and comment! |
“The astute cultivate dependence, not fleeting gratitude, leveraging a simmering hope; the memory of thanks is short, while need forges chains.”
We don’t take shortcuts, chase headlines, or push narratives. We just bring you the news, straight and fair. If you value that, click here to become a paid subscriber—your support makes all the difference.
Did you know we also write in-depth deep dives? They are long, packed with insights, and have received rave reviews. If you’re up for a detailed, action-packed read, check them out:
Baked with love,
Anna Eisenberg ❤️
What did you think of today's edition?Click to see live results and comment! |